- Home
- BNS vs GSK Comparison
BNS vs GSK Comparison
Compare BNS & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNS
- GSK
- Stock Information
- Founded
- BNS 1832
- GSK 1715
- Country
- BNS Canada
- GSK United Kingdom
- Employees
- BNS N/A
- GSK N/A
- Industry
- BNS
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- BNS
- GSK Health Care
- Exchange
- BNS Nasdaq
- GSK Nasdaq
- Market Cap
- BNS 79.7B
- GSK 81.9B
- IPO Year
- BNS N/A
- GSK N/A
- Fundamental
- Price
- BNS $66.18
- GSK $46.89
- Analyst Decision
- BNS Hold
- GSK Strong Buy
- Analyst Count
- BNS 2
- GSK 1
- Target Price
- BNS $80.00
- GSK N/A
- AVG Volume (30 Days)
- BNS 1.5M
- GSK 5.8M
- Earning Date
- BNS 12-02-2025
- GSK 10-29-2025
- Dividend Yield
- BNS 4.63%
- GSK 3.60%
- EPS Growth
- BNS N/A
- GSK 118.57
- EPS
- BNS 3.78
- GSK 1.79
- Revenue
- BNS $22,903,284,079.00
- GSK $43,237,357,842.00
- Revenue This Year
- BNS $27.74
- GSK $6.08
- Revenue Next Year
- BNS $3.62
- GSK $5.22
- P/E Ratio
- BNS $17.53
- GSK $25.82
- Revenue Growth
- BNS 7.43
- GSK 2.73
- 52 Week Low
- BNS $44.09
- GSK $31.72
- 52 Week High
- BNS $68.10
- GSK $48.69
- Technical
- Relative Strength Index (RSI)
- BNS 50.84
- GSK 56.63
- Support Level
- BNS $66.01
- GSK $45.81
- Resistance Level
- BNS $68.09
- GSK $47.98
- Average True Range (ATR)
- BNS 0.94
- GSK 0.65
- MACD
- BNS -0.13
- GSK -0.25
- Stochastic Oscillator
- BNS 39.32
- GSK 38.02
About BNS Bank Nova Scotia Halifax Pfd 3
Bank of Nova Scotia is a global financial services provider with over CAD 1.4 trillion in assets. The bank has four major business segments: Canadian banking, international banking, global wealth management, and global banking and markets. It offers a range of advice, products, and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. The bank's international operations span numerous countries and are more concentrated in the Latin America region.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.